Cancer immunotherapy – Vaccine Processing
- Dendritic Cell Therapy (5 day processing time)
- Cancer Vaccines (5 day processing time)
- Tumor infiltrating lymphocytes (TILs) vaccines
- Natural Killer-like Cell vaccines (3 weeks processing time)
- CAR-T Cell Therapy (2+ months processing time)
- PD-L1 inhibitors
- CTLA-4 inhibitors
Bladder cancer was the first indication for which an immunotherapy was granted approval by the Food and Drug Administration (FDA) in 1990.
Malignant brain tumors are relatively rare but very serious form of cancer. Immunotherapy is showing significant promise where other approaches have failed.
By far, the most significant cause of cervical cancer, as well as other ano-genital cancers, is infection with a virus—the human papillomavirus (HPV).
Colon cancer is the third most common type of cancer among both men and women in the United States, and is the second most deadly.
While many different types of cancer can occur in the head and neck, squamous cell carcinoma in the most common cancer of the head and neck.
About 9 out of every 10 kidney cancers are renal cell carcinoma cancers that form in the lining of the tubules inside the kidney.
When diagnosed early, liver cancer can be treated successfully with surgery, but liver donors are rare and few treatment options exist for patients with advanced disease.
In the U.S., lung cancer is by far the leading cause of cancer-related deaths among both men and women; causing more deaths annually than breast, prostate, and colon cancer combined.
Melanoma accounts for the majority of skin cancer-related deaths. Over the past few years, immunotherapy has dramatically changed the landscape of melanoma treatment.
Myeloma, also referred to as plasma cell myeloma, is a cancer that originates in plasma cells, a type of white blood cell that make antibodies.
Pancreatic cancer is the most lethal cancer and new therapies are urgently needed to impact pancreatic cancer treatment and to extend and save pancreatic cancer patients’ lives.
Prostate cancer is the second most common cancer in men worldwide, and the eighth leading cause of cancer-related death.
Stomach cancer is the fifth most common diagnosis in cancer, and it is the third most deadly, with nearly 725,000 deaths.
Integrative Cancer Treatment & Research Center
Subic Bay – Olongapo City,
*Immunotherapy results vary from patient to patient.